As of Jan 13
| -0.03 / -2.07%|
The 2 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 3.75, with a high estimate of 4.00 and a low estimate of 3.50. The median estimate represents a +164.08% increase from the last price of 1.42.
The current consensus among 6 polled investment analysts is to Hold stock in Arena Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.